Getinge’s organic sales growth slowed to 2.1% in the third quarter from 4.6% in the previous quarter. The slowdown was driven by persistent weakness in life science capital goods and lumpy ventilator procurement. Shares increased by 2% at the market open on Oct. 21.
Getinge benefits from stable long-term growth trends such as an aging population and increased healthcare spending, which are generally not affected by macroeconomic circumstances.
Getinge’s China business, which we estimate to be roughly 10% of total sales, is facing a slowdown, similar to that of its life science peers.
|
Metric
|
GETI B
|
MDT
|
SYK
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.23 | 16.72 | 21.82 |
Price/Book Value | 2.29 | 2.41 | 4.87 |
Price/Sales | 2.07 | 3.25 | 4.55 |
Price/Cash Flow | 13.39 | 13.58 | 20.83 |
|
Metric
|
GETI B
|
MDT
|
SYK
|
|---|---|---|---|
Quick Ratio | 0.72 | 1.29 | 1.08 |
Current Ratio | 1.25 | 2.07 | 2.16 |
Interest Coverage | 7.91 | 10.12 | — |
|
Metric
|
GETI B
|
MDT
|
SYK
|
|---|---|---|---|
Return on Assets (Normalized) | 5.37% | 8.31% | 11.44% |
Return on Equity (Normalized) | 10.11% | 15.59% | 23.97% |
Return on Invested Capital (Normalized) | 8.38% | 10.57% | 14.10% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|ZhllRJW | LOCK|>%C!n | $177B | |||
| Medtronic PLC
MDT
| LOCK|&g&<bZM | LOCK|JRC#X | $121B | |||
| Stryker Corp
SYK
| LOCK|>tl$M$^@ | LOCK|VWC | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|KlldJWS | LOCK|CB<H! | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<NpL<sN | LOCK|^>Y@ | $51B | |||
| DexCom Inc
DXCM
| LOCK|ryK#q>b% | LOCK|#F@x | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Z<Yj!! | LOCK|%#% | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Sfl | LOCK|x&J | $25B | |||
| Steris PLC
STE
| LOCK|Gr!Vj>n | LOCK|HD!^ | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|?lY%<pjD | LOCK|h# | $18B |
United States